Middle East and Africa Menstrual Cramps Treatment Market, By Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), Treatment Type (Medication, Therapy, Surgery, Others), Mode of Prescription (Over the Counter, Prescription), Route of Administration (Oral, Parenteral, Implants, Others), End User (Hospitals, Specialty Centers, Ambulatory Surgical Centers, Others), Distribution Channel (Pharmacies, Retail Sales, Direct Tender, Others), Country (Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Middle East and Africa Menstrual Cramps Treatment Market
The menstrual cramps treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.2% in the forecast period of 2021 to 2028 and is expected to reach USD 201.01 million by 2028. Rising pharmaceutical industries interest for the manufacturing plant and rising prevalence of menstrual diseases in the region are the major drivers propelling the demand of the menstrual cramps treatment market in the forecast period.
Menstrual cramps are the cramping and throbbing pain in the lower abdomen of the body. Many women have menstrual cramps before and after the menstrual periods. For some women menstrual cramps are common while for other women menstrual cramps are annoying and quite severe which interfere in daily activities for few days of every month. Symptoms of menstrual cramps are pain that starts 1 to 3 days before the period, peaks 24 hours after the onset of the period and subsides in 2 to 3 days along with dullness, continuous ache, nausea, headache, dizziness, loose stools and others.
Menstrual cramps treatment comprises features such as increasing need for effective treatment for menstrual cramps will impact in launching of new product by the manufacturers into the market which enhances its demand as well as rising government & pharmaceutical industries initiatives leads to the menstrual cramps treatment market growth. The use of alternative therapies acts as a challenge for the growth of the menstrual cramps treatment market.
Currently, awareness programmes are going on which is expected to create a competitive advantage for manufacturers to develop new and innovative technology. Moreover, these awareness programmes are also expected to provide various other opportunities in the menstrual cramps treatment market. However, presence of traditional therapies is expected to restraint the menstrual cramps treatment market growth in the forecast period.
The menstrual cramps treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the menstrual cramps treatment market scenario contact Data ridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Menstrual Cramps Treatment Market Scope and Market Size
The menstrual cramps treatment market is segmented on the basis of the type, treatment type, mode of prescription, route of administration, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the menstrual cramps treatment market is segmented into primary dysmenorrhea and secondary dysmenorrhea. In 2021, primary dysmenorrhea segment is dominating the menstrual cramps treatment market as women in the Middle East and Africa suffering from or faces menstrual cramps during their periods.
- On the basis of treatment type, the menstrual cramps treatment market is segmented into medication, therapy, surgery and others. In 2021, medication segment is dominating the menstrual cramps treatment market since medication of nonsteroidal anti-inflammatory drugs and combined oral contraceptives represent first-line therapy for dysmenorrhea pain.
- On the basis of mode of prescription, the menstrual cramps treatment market is segmented into prescription and over the counter. In 2021, over the counter segment is dominating the menstrual cramps treatment market as most of the drugs are available in generic and supply of pharmaceutical products without any hindrance raises awareness among the masses by the virtues of advertising.
- On the basis of route of administration, the menstrual cramps treatment market is segmented into oral, parenteral, implants and others. In 2021, oral segment is dominating the menstrual cramps treatment market as oral segment is considered to be the first line of treatment.
- On the basis of end user, the menstrual cramps treatment market is segmented into hospitals, ambulatory surgical centers, specialty centers and others. In 2021, hospitals segment is dominating the menstrual cramps treatment market because most of the patients are experiencing menopausal symptoms so they would be seen in the hospitals to get proper diagnosis and treatment.
- On the basis of distribution channel, the menstrual cramps treatment market is segmented into direct tender, retail sales, pharmacies and others. In 2021, pharmacies segment is dominating the menstrual cramps treatment market as variety of medicines available in the pharmacies is according to the patient needs and demand.
Middle East and Africa Menstrual Cramps Treatment Market Country Level Analysis
Middle East and Africa menstrual cramps treatment market is analysed and market size information is provided by the country, type, treatment type, mode of prescription, route of administration, end user and distribution channel as referenced above.
The countries covered in the Middle East and Africa menstrual cramps treatment market report are the Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and rest of Middle East and Africa.
Mode of prescription segment in Middle East and Africa menstrual cramps treatment market is expected to dominate due to the high adoption of OTC menstrual cramps treatment by the patients in the region. Saudi Arabia is dominating in the Middle East and Africa menstrual cramps treatment market and leading the growth due to rising presence of key market players in the region. South Africa holds the second highest market share because of rising healthcare expenditure.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Strategic Initiatives by Manufacturers is creating new opportunities for Players in the Menstrual Cramps Treatment Market
Menstrual cramps treatment market also provides you with detailed market analysis for every country growth in aesthetic industry with menstrual cramps treatment sales, impact of advancement in the menstrual cramps treatment and changes in regulatory scenarios with their support for the menstrual cramps treatment market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Menstrual Cramps Treatment Market Share Analysis
Menstrual cramps treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to menstrual cramps treatment market.
The major companies which are dealing in the Middle East and Africa menstrual cramps treatment market report are Bayer AG, GlaxoSmithKline plc, Pfizer Inc., Mylan N. V. (a part of Viatris Inc.), Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., LIVIA, Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.), Sun Pharmaceutical Industries Ltd. among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the menstrual cramps treatment market.
For instance,
- In October 2020, Bayer AG launched its first Global Creative Council. The fundamental aim of this launch is raising the bar for the Consumer Health Industry. It is predicted that this launch has anticipated bolstering the company presence in healthcare market.
Collaboration, joint ventures and other strategies by the market players is enhancing the company market in the menstrual cramps treatment market which also provides the benefit for organisation to improve their offering for menstrual cramps treatment.
SKU-